FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the Board of Directors declared an increase of 10% in the company’s quarterly cash dividend, beginning in the first quarter of 2017. The dividend increase will result in a quarterly dividend of $0.52 per share of common stock. The dividend is payable on March 30, 2017, to stockholders of record at the close of business on March 16, 2017. Future dividends will be subject to Board approval.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company’s mission is to advance the care of patients suffering from life-threatening diseases. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.